The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC).
 
Haisam Abid
No Relationships to Disclose
 
Aniko Szabo
No Relationships to Disclose
 
Bradley W. Taylor
No Relationships to Disclose
 
Aditya V. Shreenivas
No Relationships to Disclose
 
Sakti Chakrabarti
Honoraria - Haliodx; QED Therapeutics
Speakers' Bureau - Natera
 
Mandana Kamgar
Research Funding - BostonGene; Guardant Health
 
James P. Thomas
No Relationships to Disclose
 
Ben George
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Cook Medical; Eisai; Exelixis; Foundation Medicine; Ipsen; Merrimack; Roche/Genentech; Taiho Pharmaceutical; TERUMO
Research Funding - Boehringer Ingelheim (Inst); Foundation Medicine (Inst); Mirati Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Roche (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Tolero Pharmaceuticals (Inst); Toray Industries (Inst)